Over the forecast period, the worldwide auto-injectors market is expected to rise due to the rising prevalence of multiple sclerosis (MS). According to a research published in February 2019 in the journal Neurology by the National MS Society, almost 1 million persons in the United States had MS in 2017.
Patients find it convenient to use Auto-injectors as it eliminates the need for injections at the local injection site. This can be done with confidence as there is no pain involved. Patients can also go about their normal daily activities without any reminders to take their medicine as required.
Recently, in October 2019, Becton, Dickinson, and Company launched BD Intevi 1 mL two-step disposable auto-injector to administer a variety of drugs.
Read More@ https://bit.ly/3pfIwTH
